Comparison of teriparatide and calcitonin in the treatment of men and postmenopausal women with osteoporosis
Phase of Trial: Phase III
Latest Information Update: 23 Apr 2013
At a glance
- Drugs Teriparatide (Primary) ; Calcitonin
- Indications Male osteoporosis; Postmenopausal osteoporosis
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 31 Aug 2018 Biomarkers information updated
- 24 Jul 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
- 06 Mar 2008 Status changed from recruiting to in progress.